Sifting through the surfeit of neuroinflammation tracers

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  2017-12-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1177/0271678X17748786PMID 29256293PMCID PMC5951023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia

  2018cited by this paper
• Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts

  2018cited by this paper
• Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C]DPA713 versus [11C](R)PK11195

  2017cited by this paper
• Epigenetic Silencing of the Human 18 kDa Translocator Protein in a T Cell Leukemia Cell Line

  2017cited by this paper
• Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111

  2017cited by this paper
• Brain translocator protein occupancy by ONO‐2952 in healthy adults: A Phase 1 PET study using [11C]PBR28

  2017cited by this paper
• 11C-DPA-713 has much greater specific binding to translocator protein 18 kDa (TSPO) in human brain than 11C-(R)-PK11195

  2017cited by this paper
• Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714

  2017cited by this paper
• Imaging of Glial Cell Activation and White Matter Integrity in Brains of Active and Recently Retired National Football League Players

  2017cited by this paper
• Functional gains in energy and cell metabolism after TSPO gene insertion

  2017cited by this paper
• TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

  2017cited by this paper
• 11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain

  2017cited by this paper
• Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis

  2017cited by this paper
• The Variability of Translocator Protein Signal in Brain and Blood of Genotyped Healthy Humans Using In Vivo 123I-CLINDE SPECT Imaging: A Test–Retest Study

  2017cited by this paper
• Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans

  2017cited by this paper
• Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data

  2017cited by this paper
• Quantification of ONO-2952 Occupancy of 18-kDaTranslocator Protein in Conscious Monkey Brains using Positron Emission Tomography

  2017cited by this paper
• The impact of high and low dose ionising radiation on the central nervous system

  2016cited by this paper
• Global Deletion of TSPO Does Not Affect the Viability and Gene Expression Profile

  2016cited by this paper
• Translocator Protein (TSPO) Affects Mitochondrial Fatty Acid Oxidation in Steroidogenic Cells.

  2016cited by this paper
• Microglia Activation and Schizophrenia: Lessons From the Effects of Minocycline on Postnatal Neurogenesis, Neuronal Survival and Synaptic Pruning.

  2016cited by this paper
• Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain

  2016cited by this paper
• Response to Narendran and Frankle: The Interpretation of PET Microglial Imaging in Schizophrenia.

  2016cited by this paper
• Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography.

  2016cited by this paper
• In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study

  2016cited by this paper
• In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.

  2016cited by this paper
• Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates

  2016cited by this paper
• Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein

  2016cited by this paper
• In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma

  2016cited by this paper
• Comment on Analyses and Conclusions of "Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study".

  2016cited by this paper
• Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?

  2015cited by this paper
• Specific binding of [18F]fluoroethyl‐harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain

  2015cited by this paper
• The Simplified Reference Tissue Model: Model Assumption Violations and Their Impact on Binding Potential

  2015cited by this paper
• Neuroinflammation in Alzheimer's disease.

  2015cited by this paper
• Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients

  2015cited by this paper
• Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism

  2015cited by this paper
• Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects

  2015cited by this paper
• Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake.

  2015cited by this paper
• Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.

  2015cited by this paper
• Structure and activity of tryptophan-rich TSPO proteins

  2015cited by this paper
• Imaging robust microglial activation after lipopolysaccharide administration in humans with PET

  2015cited by this paper
• Mitochondrial Translocator Protein (TSPO) Function Is Not Essential for Heme Biosynthesis*

  2015cited by this paper
• Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects

  2015cited by this paper
• Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images.

  2015cited by this paper
• Optimized Quantification of Translocator Protein Radioligand 18F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers

  2015cited by this paper
• Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.

  2015cited by this paper
• Differential influence of propofol and isoflurane anesthesia in a non‐human primate on the brain kinetics and binding of [18F]DPA‐714, a positron emission tomography imaging marker of glial activation

  2015cited by this paper
• Neuroinflammation: No Rose by Any Other Name

  2014cited by this paper
• Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis.

  2014cited by this paper
• Synthesis and Evaluation of Translocator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971

  2014cited by this paper
• Determination of [11C]PBR28 Binding Potential in vivo: A First Human TSPO Blocking Study

  2014cited by this paper
• The 18 kDa Translocator Protein, Microglia and Neuroinflammation

  2014cited by this paper
• Peripheral Benzodiazepine Receptor/Translocator Protein Global Knock-out Mice Are Viable with No Effects on Steroid Hormone Biosynthesis*♦

  2014cited by this paper
• Structure of the Mitochondrial Translocator Protein in Complex with a Diagnostic Ligand

  2014cited by this paper
• Radiosynthesis and Validation of 18F-FP-CMT, a Phenyltropane with Superior Properties for Imaging the Dopamine Transporter in Living Brain

  2014cited by this paper
• Positron emission tomography and functional characterization of a complete PBR/TSPO knockout

  2014cited by this paper
• Kinetic Modeling without Accounting for the Vascular Component Impairs the Quantification of [11C]PBR28 Brain PET Data

  2014cited by this paper
• In Vivo Quantification of Cerebral Translocator Protein Binding in Humans Using 6-Chloro-2-(4′-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamide SPECT

  2014cited by this paper
• Regulation of the Mitochondrial Permeability Transition Pore by the Outer Membrane Does Not Involve the Peripheral Benzodiazepine Receptor (Translocator Protein of 18 kDa (TSPO))*

  2014cited by this paper
• Alterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation!

  2014cited by this paper
• Emergent Properties of Microglia

  2014cited by this paper
• ‘Neuroinflammation’ differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared

  2014cited by this paper
• Quantification of the Specific Translocator Protein Signal of 18F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding

  2013cited by this paper
• A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

  2013cited by this paper
• The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.

  2013cited by this paper
• Metabolism and Quantification of [18F]DPA-714, a New TSPO Positron Emission Tomography Radioligand

  2013cited by this paper
• In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients

  2013cited by this paper
• Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA

  2012cited by this paper
• The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.

  2012cited by this paper
• [¹⁸F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO).

  2012cited by this paper
• Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies

  2012cited by this paper
• Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects

  2012cited by this paper
• The 18 kDa mitochondrial translocator protein (TSPO) prevents accumulation of protoporphyrin IX. Involvement of reactive oxygen species (ROS).

  2012cited by this paper
• Structural and functional evolution of the translocator protein (18 kDa).

  2012cited by this paper
• Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain

  2012cited by this paper
• Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging

  2012cited by this paper
• Modeling the light- and redox-dependent interaction of PpsR/AppA in Rhodobacter sphaeroides.

  2011cited by this paper
• A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [(18)F]PBR102 and [(18)F]PBR111, in rat and primate plasma.

  2011cited by this paper
• An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28

  2011cited by this paper
• Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation

  2011cited by this paper
• Quantitation of Translocator Protein Binding in Human Brain with the Novel Radioligand [18F]-FEPPA and Positron Emission Tomography

  2011cited by this paper
• Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands

  2011cited by this paper
• eview athways underlying neuroprogression in bipolar disorder : Focus on nflammation , oxidative stress and neurotrophic factors

  2010cited by this paper
• Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines

  2010cited by this paper
• Preclinical Evaluation of 18F-JNJ41510417 as a Radioligand for PET Imaging of Phosphodiesterase-10A in the Brain

  2010cited by this paper
• Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation

  2010cited by this paper
• Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

  2010cited by this paper
• The development of PET radioligands for imaging the translocator protein (18 kDa): What have we learned?

  2010cited by this paper
• Autoimmune T cell responses in the central nervous system

  2009cited by this paper
• Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders

  2009cited by this paper
• Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans

  2009cited by this paper
• Quantification of Translocator Protein (18 kDa) in the Human Brain with PET and a Novel Radioligand, 18F-PBR06

  2009cited by this paper
• Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair.

  2008cited by this paper
• The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders

  2008cited by this paper
• Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors.

  2008cited by this paper
• Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS)

  2008cited by this paper
• Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation

  2008cited by this paper
• A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation

  2007cited by this paper
• [123I]Epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: Implications for the use of cerebellum as a reference region

  2007cited by this paper
• Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain

  2007cited by this paper

• N-Methyl-D-aspartate receptors as novel M1 macrophage-specific biomedical imaging nanoplatform agents: feasibility of targeted imaging in an inflammatory mice model.

  2025cites this paper
• Hemispheric asymmetry of [11C](R)PK11195 binding to translocator protein 18 kDa (TSPO) in normal brain

  2025cites this paper
• Evidence for brain glial activity in chronic migraine patients: a [11C] PBR28 PET/MR study

  2025cites this paper
• Synthesis of versatile fluorescent isoquinolinium salts and their applications.

  2025cites this paper
• Neuroinflammation and acute ischemic stroke: impact on translational research and clinical care

  2025cites this paper
• A novel blood-free analytical framework for the quantification of neuroinflammatory load from TSPO PET imaging

  2025cites this paper
• Emerging translocator protein–positron emission tomographic imaging improves detection of focal cortical dysplasia

  2025cites this paper
• A novel blood-free analytical framework for the quantification of neuroinflammatory load from TSPO PET Imaging

  2025cites this paper
• Recent developments and challenges in positron emission tomography imaging of gliosis in chronic neuropathic pain.

  2024cites this paper
• PET, SPECT, and MRI imaging for evaluation of Parkinson's disease.

  2024cites this paper
• Pathology and Treatments of Alzheimer’s Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes

  2024cites this paper
• Nicotine is an Immunosuppressant: Implications for Women's Health and Disease.

  2024cites this paper
• Microglial Positron Emission Tomography Imaging In Vivo : Positron Emission Tomography Radioligands: Utility in Research and Clinical Practice.

  2024cites this paper
• [123I]CLINDE SPECT as a neuroinflammation imaging approach in a rat model of stroke.

  2024cites this paper
• Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis

  2024cites this paper
• Alterations of the blood-brain barrier during aging

  2024cites this paper
• Neuroinflammation in the Evolution of Motor Function in Stroke and Trauma Patients: Treatment and Potential Biomarkers

  2023cites this paper
• Concussion: Beyond the Cascade

  2023cites this paper
• Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution

  2023cites this paper
• Visualization of Thromboinflammation by 18F-DPA-714 PET in a Stroke Patient.

  2023cites this paper
• TSPO PET BRAIN INFLAMMATION IMAGING: A TRANSDIAGNOSTIC SYSTEMATIC REVIEW AND META-ANALYSIS OF 156 CASE-CONTROL STUDIES

  2023cites this paper
• Spirocyclic Iodonium Ylides for Fluorine‐18 Radiolabeling of Non‐Activated Arenes: From Concept to Clinical Research

  2023cites this paper
• Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease

  2023cites this paper
• Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis

  2023cites this paper
• The Sensitivity of Tau Tracers for the Discrimination of Alzheimer’s Disease Patients and Healthy Controls by PET

  2023cites this paper
• Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand.

  2023cites this paper
• Molecular Imaging Studies of Alcohol Use Disorder.

  2023cites this paper
• Characterization of neuroinflammatory positron emission tomography biomarkers in chronic traumatic encephalopathy

  2022cites this paper
• Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer's Disease.

  2022cites this paper
• Brain sex-dependent alterations after prolonged high fat diet exposure in mice

  2022cites this paper
• Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies

  2022cites this paper
• Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update

  2022cites this paper
• Assessing organ-level immunoreactivity in a rat model of sepsis using TSPO PET imaging

  2022cites this paper
• Meta-analysis of molecular imaging of translocator protein in major depression

  2022influential citation
• The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response.

  2022cites this paper
• Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders

  2022cites this paper
• Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.

  2022cites this paper
• A single dose of ketamine cannot prevent protracted stress-induced anhedonia and neuroinflammation in rats

  2022cites this paper
• Immune responses in the Parkinson ’ s disease brain Neurobiology of Disease

  2022cites this paper
• Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria.

  2021cites this paper
• Parametric Mapping for TSPO PET Imaging with Spectral Analysis Impulsive Response Function

  2021cites this paper
• Detection of Alzheimer’s disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein

  2021cites this paper
• Preclinical Evaluation of TSPO and MAO-B PET Radiotracers in an LPS Model of Neuroinflammation.

  2021cites this paper
• In Vitro Evaluation of [3H]CPPC as a Tool Radioligand for CSF-1R.

  2021cites this paper
• Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain

  2021cites this paper
• TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy.

  2021cites this paper
• Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology

  2021cites this paper
• Population-based input function for TSPO quantification and kinetic modeling with [11C]-DPA-713

  2021cites this paper
• In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease

  2021cites this paper
• Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation

  2021cites this paper
• A binge high sucrose diet provokes systemic and cerebral inflammation in rats without inducing obesity

  2021cites this paper
• Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease

  2021cites this paper
• Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation

  2021cites this paper
• MRI and PET of Brain Tumor Neuroinflammation in the Era of Immunotherapy, From the AJR Special Series on Inflammation.

  2021cites this paper
• TSPO: an emerging role in appetite for a therapeutically promising biomarker

  2021cites this paper
• Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies

  2021cites this paper
• Preclinical evaluation of (S)-[18F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971

  2021cites this paper
• Direct Comparison of [18F]F-DPA with [18F]DPA-714 and [11C]PBR28 for Neuroinflammation Imaging in the same Alzheimer’s Disease Model Mice and Healthy Controls

  2021cites this paper
• The aryl hydrocarbon receptor: a diagnostic and therapeutic target in glioma.

  2021cites this paper
• Neuroinflammation in the Cerebellum and Brainstem in Friedreich Ataxia: An [18F]‐FEMPA PET Study

  2021cites this paper
• Mitochondrial Translocator Protein (TSPO) Expression in the Brain After Whole Body Gamma Irradiation

  2021cites this paper
• Central Nervous System Molecular Imaging

  2021cites this paper
• 18F-GE180, a failed tracer for translocator protein, has no place in child abuse imaging

  2021cites this paper
• In Vivo Cerebral Translocator Protein (TSPO) Binding and Its Relationship with Blood Adiponectin Levels in Treatment-Naïve Young Adults with Major Depression: A [11C]PK11195 PET Study

  2021cites this paper
• Feasibility of Population-Based Input Function for Kinetic Modeling of [11C]-DPA-713

  2020cites this paper
• Personality traits in psychosis and psychosis risk linked to TSPO expression: a neuroimmune marker

  2020cites this paper
• Molecular imaging of schizophrenia: neurochemical findings in a heterogeneous and evolving disorder.

  2020cites this paper
• Recent developments on PET radiotracers for TSPO and their applications in neuroimaging

  2020cites this paper
• Regulation of blood–brain barrier integrity by microglia in health and disease: A therapeutic opportunity

  2020cites this paper
• Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies

  2020cites this paper
• In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein

  2020cites this paper
• Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases

  2020cites this paper
• Neuronal activity increases translocator protein (TSPO) levels

  2020cites this paper
• Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in AppNL-G-F mice

  2020cites this paper
• 18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis

  2020cites this paper
• Perspective: Solving the Heterogeneity Conundrum of TSPO PET Imaging in Psychosis

  2020cites this paper
• Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio

  2020cites this paper
• Multi-target PET evaluation in APP/PS1/tau mouse model of Alzheimer's disease.

  2020cites this paper
• The Translocator Protein (TSPO) in Mitochondrial Bioenergetics and Immune Processes

  2020cites this paper
• Anatomy of 18F-GE180, a failed radioligand for the TSPO protein

  2020cites this paper
• Tobacco Smoking in People Is Not Associated with Altered 18-kDa Translocator Protein Levels: A PET Study

  2020cites this paper
• Widespread microglial activation in multiple system atrophy

  2019cites this paper
• The validity of 18F-GE180 as a TSPO imaging agent

  2019cites this paper
• Insight into the Structural Features of TSPO: Implications for Drug Development.

  2019cites this paper
• A Comparative Study of in vitro Assays for Predicting the Nonspecific Binding of PET Imaging Agents in vivo

  2019cites this paper
• Novel imaging markers for neuroinflammation in multiple sclerosis

  2019cites this paper
• Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [11C]PBR28 HRRT PET study

  2019cites this paper
• Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging.

  2019cites this paper
• Modified benzoxazolone (ABO‐AA) based single photon emission computed tomography (SPECT) probes for 18 kDa translocator protein

  2019cites this paper
• Head-to-head comparison of 11C-PBR28 and 11C-ER176 for quantification of the translocator protein in the human brain

  2019cites this paper
• Neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein

  2019cites this paper
• Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders.

  2019cites this paper
• Current and Future Cardiovascular PET Radiopharmaceuticals.

  2019cites this paper
• TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.

  2019cites this paper
• In response to: The validity of 18F-GE180 as a TSPO imaging agent

  2019cites this paper
• Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease

  2018cites this paper
• Reliability, replicability and reproducibility in PET imaging

  2018cites this paper
• In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET

  2018cites this paper
• Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study

  2018cites this paper
• Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies

  2018cites this paper